Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B

Lamivudine therapy in patients with chronic hepatitis B can induce the recovery of antiviral T cell responses. It is unknown whether the recovery of T cell responsiveness is long-lasting and persists throughout the treatment and whether the elevation of viremia which follows therapy withdrawal can restore a condition of T cell unresponsiveness

Absence of zidovudine resistance in anti retroviral-naive patients following zidovudine/lamivudine/protease inhibitor combination therapy: Virological evaluation of the AVANTI 2 and AVANTI 3 studies

SCOPUS: ar.jinfo:eu-repo/semantics/publishe